-
Document de presse | 2010.09.19
Bacteria disseminate resistance even in the absence of antibiotics
Institut Pasteur researchers in the Antibacterial Agents Unit, directed by Patrice Courvalin, studied resistance to vancomycin in enterococcus bacteria and demonstrated why the mechanism of resistance to this antibiotic has spread so effectively throughout the world. It was previously believed that only large-scale antibiotic use would be responsible for the resistance spread. However, this study...
-
Document de presse | 2010.02.14
Customized stem cells to help treat leukemia?
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS) have just discovered the origin of hematopoietic stem cells (HSC), which give rise to all blood and immune cells in the body. Using real-time imaging technology on zebrafish embryos, the researchers observed that these stem cells were formed from the cells of the aortic wall, the embryo's main...
-
Document de presse | 2009.02.04
A yeast for studying neurodegenerative diseases
A team from the Institut Pasteur working with the CNRS (French National Center for Scientific Research) has shown in an article published in the EMBO Journal that a yeast can be used as a cell model for a rare and severe neurodegenerative disease affecting adolescents. This discovery could provide researchers with an unexpected and particularly effective tool for studying the genetics of this...
-
Document de presse | 2008.07.07
Whooping cough: bacterial monitoring for better prevention
Researchers from the Institut Pasteur in Paris and the Institut Pasteur in Lille have analyzed the consequences of intensive vaccination of young children against whooping cough on the bacterium agent of the disease. Their observations highlight the importance of continuing bacterial evolution in order to adapt vaccine strategies. Press release Paris, july 8, 2008 ...
-
Document de presse | 2006.06.25
Hereditary deafness - Discovery of a gene essential for a proper communication between the ear and the brain
Professor Christine Petit's team at the Institut Pasteur Genetics of Sensory Defects Unit, in collaboration with INSERM* and the Collège de France, has recently identified mutations in a gene which, contrary to all other mutations of the deafness genes identified to date, do not cause a dysfunction in the auditory sensory organ, the cochlea. Based on the development of a mouse model, the...
-
Document de presse | 2005.10.12
Institut Pasteur and Total join forces to combat infectious diseases
On October 13, Total and Institut Pasteur signed a corporate funding agreement intended to strengthen the scientific and human resources allocated to the fight against infectious diseases, especially sexually transmitted diseases (STD). The five-year agreement covers two areas. Press release Paris, october 13, 2005 · Support for Institut Pasteur’s research...
-
Document de presse | 2005.06.27
Gates millions for vaccine research The fight against hepatitis C and HIV: foundation supports international consortium
The Bill and Melinda Gates Foundation (Seattle, USA) has decided to fund an international research consortium led by the German Research Centre of Biotechnology (GBF) in Braunschweig and the Institut Pasteur in Paris. The long-term goal of the 9 million dollar project is the development of vaccines against Hepatitis C and HIV. Press release Paris, june 28, 2005 “...
-
Document de presse | 2005.06.23
INRS–Institut Armand-Frappier (Canada) Joins the Réseau International des Instituts Pasteur And Supports Global Appeal to Boost Attention to Neglected Diseases
The INRS–Institut Armand-Frappier research centre, located in Laval, close to Montreal (Canada), recently joined the Réseau International des Instituts Pasteur (RIIP) which now has 29 member institutions on five continents. The INRS–Institut Armand-Frappier research centre is the first North American institution to join the RIIP network. Press release Paris, june 24,...
-
Document de presse | 2005.04.18
Newborn susceptibility to infection now deciphered
A joint Institut Pasteur-Inserm team has deciphered key mechanisms in the development of newborn immune systems. This study has made it possible to understand why infants are susceptible to early infections that cause high mortality rates, particularly in developing countries. Understanding these mechanisms offers possibilities for new types of treatment and vaccines adapted to protect newborns...
-
Document de presse | 2004.09.29
Procter & Gamble And Institut Pasteur Announce A Joint Collaboration To Develop A New Therapeutic Approach For Asthma
Procter & Gamble Pharmaceuticals (P&GP), a subsidiary of The Procter & Gamble Co. (NYSE: PG), and Institut Pasteur today announced an agreement under which P&GP will develop and seek market authorization for drug candidate EFD, a new type of immuno-modulator for the treatment of asthma and other allergic disorders, stemming from a joint research collaboration between Institut...